Antibody Treatment May Be Less Effective On Omicron: US Biotech Firm
US biotech firm Regeneron said Tuesday that its synthetic antibody treatment for Covid-19 may be less effective against the new variant, and it plans to conduct tests to determine by how much.
No comments:
Post a Comment